MetricSide LogoMetricSide
Learn
  1. Home
  2. Stocks
  3. Healthcare
  4. ABBV
OverviewMetricsPricesGrowthEfficiencyValuationBalanceCash & Capital
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

© 2026 MetricSide. All rights reserved. Data provided for informational purposes only.

AbbVie Inc. (ABBV) Financial Metrics

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$235.66
12.5%
Market Cap
$417.12B
12.6%

ABBV trades at $235.66, a 12.5% increase year-over-year. Market capitalization stands at $417.12B, up 12.6% from the prior year. Track ABBV price trends and market cap history to understand how the market values this company over time.

Stock Price
Closing price at quarter end
Market Cap
Valuation at quarter end

Growth

Revenue and earnings growth across quarters

TTM Revenue
$62.82B
9.5%
Q. Revenue
$15.00B
TTM EBITDA
$23.37B
26.8%
Q. Op. Income
$3.99B
TTM Net Income
$3.63B
13.3%
Q. Net Income
$695.00M

$62.82B in TTM revenue grew 9.5% YoY, reaching $15.00B last quarter. TTM EBITDA of $23.37B on operating income of $3.99B shows growth is flowing through. Net income of $3.63B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.

TTM Revenue
Trailing twelve months revenue
Quarterly Revenue
Single quarter revenue
TTM EBITDA
Trailing twelve months EBITDA
Quarterly EBITDA
Single quarter EBITDA
Quarterly Operating Income
Single quarter operating income
TTM Net Income
Trailing twelve months profit
Quarterly Net Income
Single quarter profit

Balance Sheet

Assets, cash, debt, and leverage

Total Assets
$136.46B
Long-Term Debt
$64.53B
D/E
N/A
Equity
$-6.66B
Total Assets
Total assets reported on balance sheet
Cash & Equivalents
Cash and short-term investments
Long-Term Debt
Total long-term debt obligations
Debt / Equity
Long-term debt divided by stockholders equity
Debt / EBITDA
Long-term debt divided by quarterly EBITDA

Valuation

Price multiples and return ratios

Market Cap
$417.12B
P/E
114.8x
P/S
6.6x
P/B
N/A

At 114.8x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 6.6x and P/B of 0.0x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.

P/E Ratio
Historical market cap / TTM net income
P/S Ratio
Historical market cap / TTM revenue
P/B Ratio
Historical market cap / stockholders equity
EV / EBITDA
Enterprise value to EBITDA multiple
FCF Yield (%)
Free cash flow / market cap
Earnings Yield (%)
TTM Net Income / Market Cap
Return on Equity (ROE)
TTM net income / stockholders equity

Efficiency

Operating efficiency and return metrics

Op. Margin
26.6%
4.9%
Net Margin
4.6%
51.9%
ROE
N/A
Gross Margin
71.9%

Op. margin of 26.6% is down 1.4% YoY — costs are rising relative to revenue. Net margin at 4.6% and gross margin of 71.9%.

Margins (%)
Operating vs Net Margin
EBITDA Margin (%)
EBITDA as % of Revenue
Asset Turnover
TTM Revenue / Total Assets
Return on Assets (ROA)
TTM Net Income / Total Assets
Revenue per Share
TTM Revenue / Shares Outstanding

Cash & Capital

Free cash flow, earnings quality, and capital allocation

Free Cash Flow
$3.56B
154.6%
Op. Cash Flow
$3.83B
Shares Out.
1.77B
0.1%
Cash & Equiv.
$9.39B

FCF of $3.56B on $3.83B in operating cash flow. The FCF / Net Income ratio of 1.0x means earnings are well backed by actual cash — high-quality earnings. Cash reserves of $9.39B provide financial flexibility. Share count is stable — no dilution or buyback activity.

Free Cash Flow
Operating cash flow minus CapEx
FCF Margin (%)
FCF as % of TTM Revenue
FCF / Net Income
Earnings quality: FCF relative to reported profit
Shares Outstanding
Common shares outstanding (dilution / buybacks)
Book Value (Equity)
Total stockholders equity